Work

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

Year: 2014

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu463

Authors: Q. Zhou, Y. Cheng, J.-J. Yang, M.-F. Zhao, L. Zhang, X.-C. Zhang, Z.-H. Chen, H.-H. Yan, Y. Song, J.-H. Chen, W.-N. Feng, C.-R. Xu, Z. Wang, H.-J. Chen, W.-Z. Zhong, Y.-P. Liu, Y.-L. Wu

Institutions: Guangdong General Hospital, Guangdong Academy of Medical Sciences, Jilin Province Tumor Hospital, First Hospital of China Medical University, Nanjing General Hospital of Nanjing Military Command, Nanjing University, Hunan Cancer Hospital, First People's Hospital of Foshan

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2040318364

FWCI: 8.964

Cites: 33

Cited by: 67

Related to: 10